TIGIT antibody (Extracellular Domain) (Biotin)
Quick Overview for TIGIT antibody (Extracellular Domain) (Biotin) (ABIN6992251)
Target
See all TIGIT AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- Extracellular Domain
-
Purification
- TIGIT Antibody is supplied as protein A purified IgG1.
-
Immunogen
- TIGIT antibody was raised against the extracellular domain of human TIGIT
-
Isotype
- IgG1
-
-
-
-
Application Notes
- TIGIT antibody can be used for as detection antibody in Sandwich Elisa at 1 μ,g/mL.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- TIGIT Antibody is supplied in PBS containing 1 % BSA and 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,4 °C
-
Storage Comment
- TIGIT antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
- TIGIT (T Cell Immunoreceptor with Ig and ITIM Domains (TIGIT))
-
Alternative Name
- TIGIT
-
Background
- TIGIT Antibody: The T cell immunoreceptor with Ig and ITIM domains (TIGIT) is a member of the PVR (poliovirus receptor) family of immunoglobin proteins. It is expressed on several classes of T cells including follicular B helper T cells (TFH). TIGIT has been shown to bind PVR with high affinity, this binding is thought to assist interactions between TFH and dendritic cells to regulate T cell dependent B cell responses (1). Similar to other immune checkpoint proteins such as PD-1, TIGIT is upregulated on exhausted T cells in chronic viral infections and cancer. Blockade of both TIGIT and PD-1 pathways leads to tumor rejection in mice suggesting that it may be of therapeutic use against cancer (2).
-
Gene ID
- 201633
-
NCBI Accession
- NP_776160
-
UniProt
- Q495A1
-
Pathways
- Cancer Immune Checkpoints
Target
-